AI-Driven Peptide Synthesis Platform for Drug Discovery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional drug discovery methods are inefficient, limited in application, and often result in ineffective or dangerous therapeutics, particularly for diseases like prosthetic joint infections, due to their reliance on small design spaces and inability to handle complex biological data effectively.
Innovation Solution
An artificial intelligence engine that uses machine learning models and causal inference to generate candidate drug compounds by expanding the design space to include structural, physical, semantic, and chemical information, optimizing the synthesis process through automated flow chemistry and real-time monitoring of chemical reactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional drug discovery methods are used, then the process is simpler and more familiar, but the efficiency is low and the design space is limited
Solution Approach 1:
The patent replaces conventional mechanical and manual drug discovery methods with an artificial intelligence system that uses machine learning models and causal inference algorithms. The AI engine automatically analyzes structural, physical, semantic, and chemical information to generate candidate drug compounds, substituting human-driven processes with computational intelligence to achieve higher efficiency and expanded design space exploration.
Solution Approach 2:
The patent integrates multiple types of information (structural, physical, semantic, and chemical data) into a composite AI-driven drug discovery system. This composite approach combines diverse data sources and analytical methods within a unified AI platform, enabling comprehensive analysis and generation of superior candidate compounds that leverage the strengths of each information type.
2Reliability
If conventional methods are used, then resource consumption is lower, but therapeutic outcomes are ineffective or dangerous
Solution Approach 1:
The AI engine performs preliminary analysis and prediction of candidate drug compound properties before actual synthesis and testing. By using machine learning models to predict efficacy and safety characteristics in silico, the system identifies promising candidates upfront, reducing the need for extensive trial-and-error experimentation and thereby lowering resource consumption while improving therapeutic reliability.
Solution Approach 2:
The system implements feedback mechanisms where experimental results and real-world performance data are fed back into the AI engine to continuously refine and improve the machine learning models. This feedback loop enhances the reliability of therapeutic predictions over time, enabling more accurate identification of effective and safe drugs while optimizing resource allocation by focusing on high-probability candidates.
3Measurement precision
If a small design space is used, then the search process is faster, but the accuracy and diversity of candidate compounds are limited
Solution Approach 1:
The patent expands the design space exploration by incorporating multiple dimensions of information simultaneously - structural, physical, semantic, and chemical properties. This multi-dimensional approach allows the AI engine to explore a vastly enlarged design space efficiently by processing diverse data types in parallel, achieving both high accuracy in candidate identification and reasonable exploration time through dimensional expansion rather than sequential searching.
Data Source
AI summary
In one aspect, a method is disclosed wherein an artificial intelligence (AI) enabled automated flow synthesis platform is configured to generate optimized synthesizing recipes which enable a sequence to be synthesized using an automated flow process. The method includes receiving a synthesizing recipe including parameters used during the automated flow process to synthesize the sequence, receiving spectral data from detectors monitoring the automated flow process in a reaction chamber, where the spectral data corresponds to a reaction point in the automated flow process, and determining, based on indicators associated with the spectral data, characteristics of a chemical reaction at the reaction point in the automated flow process. An artificial intelligence engine determines the chemical reaction. The method includes associating, based on the spectral data, the synthesizing recipe with the chemical reaction.